Related Experiment Video
Updated: Feb 22, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
5.3K
Improving Medication Adherence in Coronary Heart Disease
Leah L Zullig1,2, Katherine Ramos3,4, Hayden B Bosworth5,6,7,8
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Health Care System, 411 West Chapel Hill Street, Suite 600, Durham, NC, 27701, USA.
Current Cardiology Reports
|September 24, 2017
Summary
Improving medication adherence in coronary heart disease (CHD) patients involves patient-provider communication, mHealth tools, education, and psychosocial support. Research is ongoing to confirm intervention effectiveness and long-term outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Health Services Research
Background:
- Medication adherence is crucial for managing coronary heart disease (CHD).
- Recent randomized controlled trials (RCTs) have explored various strategies to improve adherence.
- Understanding effective interventions across all adherence phases is essential for patient outcomes.
Purpose of the Study:
- To synthesize findings from recent RCTs on medication adherence in CHD patients.
- To identify successful strategies and promising practices for enhancing medication adherence.
- To examine interventions targeting different phases of medication adherence, including initiation, implementation, and discontinuation.
Main Methods:
- Systematic review of recently published randomized controlled trials (RCTs).
- Inclusion of studies targeting any phase of medication adherence in patients with CHD.
- Analysis of intervention strategies, adherence phases addressed, and outcome measures used.
Main Results:
- Effective strategies include enhanced patient-provider communication, mHealth technologies with two-way communication, integrated patient education with lifestyle counseling, and psychosocial support.
- All reviewed studies focused on medication implementation, with one addressing initiation; none addressed discontinuation.
- Outcome measures varied, with a tendency towards subjective adherence measures; findings on specific intervention designs were mixed.
Conclusions:
- Promising practices for improving medication adherence in CHD patients have been identified.
- Further research is necessary to evaluate the effectiveness, scalability, and durability of these interventions.
- Addressing all phases of medication adherence, including discontinuation, requires further investigation.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
746
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
746
01:27Coronary Artery Disease V: Interprofessional Care
321
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
321
01:28Acute Coronary Syndrome IV: Interprofessional Care
321
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
321
01:26Atherosclerosis III: Management
476
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
476
01:30Heart Failure V: Medical Management
392
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
392
01:20Angina V: Nursing Management
385
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
385